Mark James Litton - Aug 17, 2021 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role
Chief Operating Officer
Signature
/s/ Glenna Mileson, Attorney-in-fact on behalf of Mark Litton
Stock symbol
ATHA
Transactions as of
Aug 17, 2021
Transactions value $
$80,622
Form type
4
Date filed
8/19/2021, 05:05 PM
Next filing
Jan 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATHA Common Stock Award $12.5K +867 +1.36% $14.45* 64.4K May 18, 2021 Direct F1, F2, F3
transaction ATHA Common Stock Options Exercise $68.1K +50.4K +78.28% $1.35 115K Aug 17, 2021 Direct
holding ATHA Common Stock 6.56K Aug 17, 2021 By Irrevocable Trust of OSL F4
holding ATHA Common Stock 6.56K Aug 17, 2021 By Irrevocable Trust of SWL F5
holding ATHA Common Stock 6.56K Aug 17, 2021 By Irrevocable Trust of WGL F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATHA Stock Option (Right to Buy) Options Exercise $0 -50.4K -33.33% $0.00 101K Aug 17, 2021 Common Stock 50.4K $1.35 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Athira Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the ESPP Purchase Period (as defined in the ESPP) of September 17, 2020 through May 18, 2021. This transaction is also exempt under Rule 16b-3(c).
F2 The Purchase Period ended May 18, 2021 and is the Purchase Period comprising the Offering Period (as defined in the ESPP) that began September 17, 2020.
F3 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the initial public offering price from the issuer's initial public offering.
F4 Reflects Common Stock held by Irrevocable Trust of OSL held for the benefit of Dr. Litton's children.
F5 Reflects Common Stock held by Irrevocable Trust of SWL held for the benefit of Dr. Litton's children.
F6 Reflects Common Stock held by Irrevocable Trust of WGL held for the benefit of Dr. Litton's children.
F7 One-fourth of the shares subject to the option vested on July 1, 2020 and one-fourth of the shares subject to the option vest on each year thereafter.